nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—SLC22A1—Latanoprost—glaucoma	0.283	0.618	CbGbCtD
Amantadine—SLC22A1—Clonidine—glaucoma	0.105	0.229	CbGbCtD
Amantadine—ABCB1—Timolol—glaucoma	0.0377	0.0825	CbGbCtD
Amantadine—ABCB1—Clonidine—glaucoma	0.032	0.0701	CbGbCtD
Amantadine—Nausea—Methazolamide—glaucoma	0.00038	0.000865	CcSEcCtD
Amantadine—Hypotension—Dorzolamide—glaucoma	0.000379	0.000863	CcSEcCtD
Amantadine—Dyspnoea—Brimonidine—glaucoma	0.000379	0.000862	CcSEcCtD
Amantadine—Somnolence—Brimonidine—glaucoma	0.000378	0.00086	CcSEcCtD
Amantadine—Mental disorder—Clonidine—glaucoma	0.000378	0.000859	CcSEcCtD
Amantadine—Hypotension—Travoprost—glaucoma	0.000378	0.000859	CcSEcCtD
Amantadine—Tachycardia—Pilocarpine—glaucoma	0.000374	0.000852	CcSEcCtD
Amantadine—Dyspepsia—Brimonidine—glaucoma	0.000374	0.000851	CcSEcCtD
Amantadine—Hallucination—Betaxolol—glaucoma	0.000374	0.00085	CcSEcCtD
Amantadine—Hypotension—Brinzolamide—glaucoma	0.000373	0.000848	CcSEcCtD
Amantadine—Hyperhidrosis—Pilocarpine—glaucoma	0.000371	0.000844	CcSEcCtD
Amantadine—Tension—Clonidine—glaucoma	0.000368	0.000838	CcSEcCtD
Amantadine—Insomnia—Dorzolamide—glaucoma	0.000367	0.000835	CcSEcCtD
Amantadine—Gastrointestinal disorder—Brimonidine—glaucoma	0.000367	0.000835	CcSEcCtD
Amantadine—Fatigue—Brimonidine—glaucoma	0.000367	0.000834	CcSEcCtD
Amantadine—Anorexia—Pilocarpine—glaucoma	0.000366	0.000832	CcSEcCtD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000366	0.00353	CbGpPWpGaD
Amantadine—GRIN1—Alzheimers Disease—BAD—glaucoma	0.000366	0.00353	CbGpPWpGaD
Amantadine—Feeling abnormal—Acetazolamide—glaucoma	0.000365	0.00083	CcSEcCtD
Amantadine—Hypersensitivity—Apraclonidine—glaucoma	0.000365	0.00083	CcSEcCtD
Amantadine—Nervousness—Clonidine—glaucoma	0.000365	0.000829	CcSEcCtD
Amantadine—Paraesthesia—Dorzolamide—glaucoma	0.000365	0.000829	CcSEcCtD
Amantadine—GRIN1—Spinal Cord Injury—BDNF—glaucoma	0.000362	0.0035	CbGpPWpGaD
Amantadine—Dyspnoea—Dorzolamide—glaucoma	0.000362	0.000823	CcSEcCtD
Amantadine—Visual impairment—Betaxolol—glaucoma	0.000362	0.000823	CcSEcCtD
Amantadine—Insomnia—Brinzolamide—glaucoma	0.000361	0.000821	CcSEcCtD
Amantadine—Somnolence—Dorzolamide—glaucoma	0.000361	0.000821	CcSEcCtD
Amantadine—Dyspnoea—Travoprost—glaucoma	0.00036	0.00082	CcSEcCtD
Amantadine—GRIN2A—Neuronal System—SLC6A1—glaucoma	0.00036	0.00348	CbGpPWpGaD
Amantadine—Hypotension—Pilocarpine—glaucoma	0.000359	0.000815	CcSEcCtD
Amantadine—Paraesthesia—Brinzolamide—glaucoma	0.000358	0.000815	CcSEcCtD
Amantadine—Dyspepsia—Dorzolamide—glaucoma	0.000357	0.000813	CcSEcCtD
Amantadine—GRIN2B—Alzheimers Disease—BAD—glaucoma	0.000356	0.00345	CbGpPWpGaD
Amantadine—Dyspnoea—Brinzolamide—glaucoma	0.000356	0.00081	CcSEcCtD
Amantadine—Dyspepsia—Travoprost—glaucoma	0.000356	0.000809	CcSEcCtD
Amantadine—GRIN1—Axon guidance—NCK2—glaucoma	0.000356	0.00344	CbGpPWpGaD
Amantadine—Asthenia—Apraclonidine—glaucoma	0.000355	0.000808	CcSEcCtD
Amantadine—GRIN1—BDNF signaling pathway—NGFR—glaucoma	0.000355	0.00343	CbGpPWpGaD
Amantadine—Somnolence—Brinzolamide—glaucoma	0.000355	0.000807	CcSEcCtD
Amantadine—Vision blurred—Clonidine—glaucoma	0.000354	0.000805	CcSEcCtD
Amantadine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000354	0.00342	CbGpPWpGaD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000353	0.00341	CbGpPWpGaD
Amantadine—Decreased appetite—Dorzolamide—glaucoma	0.000353	0.000803	CcSEcCtD
Amantadine—Tremor—Clonidine—glaucoma	0.000352	0.0008	CcSEcCtD
Amantadine—Dyspepsia—Brinzolamide—glaucoma	0.000351	0.000799	CcSEcCtD
Amantadine—Eye disorder—Betaxolol—glaucoma	0.000351	0.000798	CcSEcCtD
Amantadine—Pruritus—Apraclonidine—glaucoma	0.00035	0.000797	CcSEcCtD
Amantadine—DRD2—Circadian rythm related genes—OPN4—glaucoma	0.00035	0.00339	CbGpPWpGaD
Amantadine—Body temperature increased—Acetazolamide—glaucoma	0.00035	0.000797	CcSEcCtD
Amantadine—Fatigue—Dorzolamide—glaucoma	0.00035	0.000796	CcSEcCtD
Amantadine—Gastrointestinal disorder—Travoprost—glaucoma	0.000349	0.000794	CcSEcCtD
Amantadine—Fatigue—Travoprost—glaucoma	0.000349	0.000793	CcSEcCtD
Amantadine—Cardiac disorder—Betaxolol—glaucoma	0.000348	0.000793	CcSEcCtD
Amantadine—GRIN1—Spinal Cord Injury—IL1A—glaucoma	0.000348	0.00336	CbGpPWpGaD
Amantadine—Insomnia—Pilocarpine—glaucoma	0.000347	0.000789	CcSEcCtD
Amantadine—Decreased appetite—Brinzolamide—glaucoma	0.000347	0.000789	CcSEcCtD
Amantadine—GRIN2B—Axon guidance—NCK2—glaucoma	0.000347	0.00335	CbGpPWpGaD
Amantadine—GRIN2B—BDNF signaling pathway—NGFR—glaucoma	0.000346	0.00335	CbGpPWpGaD
Amantadine—Constipation—Travoprost—glaucoma	0.000346	0.000786	CcSEcCtD
Amantadine—Agitation—Clonidine—glaucoma	0.000345	0.000785	CcSEcCtD
Amantadine—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000345	0.000784	CcSEcCtD
Amantadine—Paraesthesia—Pilocarpine—glaucoma	0.000345	0.000784	CcSEcCtD
Amantadine—Asthenia—Bimatoprost—glaucoma	0.000345	0.000784	CcSEcCtD
Amantadine—Fatigue—Brinzolamide—glaucoma	0.000344	0.000783	CcSEcCtD
Amantadine—Dyspnoea—Pilocarpine—glaucoma	0.000342	0.000778	CcSEcCtD
Amantadine—Somnolence—Pilocarpine—glaucoma	0.000341	0.000776	CcSEcCtD
Amantadine—Angiopathy—Betaxolol—glaucoma	0.000341	0.000775	CcSEcCtD
Amantadine—Pruritus—Bimatoprost—glaucoma	0.00034	0.000773	CcSEcCtD
Amantadine—Diarrhoea—Apraclonidine—glaucoma	0.000339	0.000771	CcSEcCtD
Amantadine—Mediastinal disorder—Betaxolol—glaucoma	0.000338	0.00077	CcSEcCtD
Amantadine—Dyspepsia—Pilocarpine—glaucoma	0.000338	0.000768	CcSEcCtD
Amantadine—GRIN1—BDNF signaling pathway—NTRK1—glaucoma	0.000337	0.00326	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000337	0.00326	CbGpPWpGaD
Amantadine—Arrhythmia—Betaxolol—glaucoma	0.000335	0.000763	CcSEcCtD
Amantadine—Feeling abnormal—Dorzolamide—glaucoma	0.000335	0.000761	CcSEcCtD
Amantadine—Decreased appetite—Pilocarpine—glaucoma	0.000334	0.000759	CcSEcCtD
Amantadine—Feeling abnormal—Travoprost—glaucoma	0.000333	0.000758	CcSEcCtD
Amantadine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000333	0.00321	CbGpPWpGaD
Amantadine—Alopecia—Betaxolol—glaucoma	0.000332	0.000755	CcSEcCtD
Amantadine—Palpitations—Clonidine—glaucoma	0.000332	0.000755	CcSEcCtD
Amantadine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000331	0.000753	CcSEcCtD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000329	0.00318	CbGpPWpGaD
Amantadine—Feeling abnormal—Brinzolamide—glaucoma	0.000329	0.000748	CcSEcCtD
Amantadine—Mental disorder—Betaxolol—glaucoma	0.000329	0.000748	CcSEcCtD
Amantadine—GRIN2B—BDNF signaling pathway—NTRK1—glaucoma	0.000329	0.00318	CbGpPWpGaD
Amantadine—Constipation—Pilocarpine—glaucoma	0.000328	0.000746	CcSEcCtD
Amantadine—DDC—Metabolism—CA5A—glaucoma	0.000328	0.00317	CbGpPWpGaD
Amantadine—DDC—Metabolism—NARFL—glaucoma	0.000328	0.00317	CbGpPWpGaD
Amantadine—Dizziness—Apraclonidine—glaucoma	0.000328	0.000745	CcSEcCtD
Amantadine—Malnutrition—Betaxolol—glaucoma	0.000327	0.000743	CcSEcCtD
Amantadine—DDC—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000324	0.00313	CbGpPWpGaD
Amantadine—Body temperature increased—Dorzolamide—glaucoma	0.000321	0.00073	CcSEcCtD
Amantadine—Tension—Betaxolol—glaucoma	0.000321	0.00073	CcSEcCtD
Amantadine—Agranulocytosis—Timolol—glaucoma	0.000319	0.000725	CcSEcCtD
Amantadine—Anxiety—Clonidine—glaucoma	0.000319	0.000724	CcSEcCtD
Amantadine—Asthenia—Acetazolamide—glaucoma	0.000318	0.000723	CcSEcCtD
Amantadine—Dizziness—Bimatoprost—glaucoma	0.000318	0.000722	CcSEcCtD
Amantadine—Nervousness—Betaxolol—glaucoma	0.000317	0.000722	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000317	0.000722	CcSEcCtD
Amantadine—DDC—Circadian rythm related genes—NGFR—glaucoma	0.000317	0.00306	CbGpPWpGaD
Amantadine—Feeling abnormal—Pilocarpine—glaucoma	0.000316	0.000719	CcSEcCtD
Amantadine—Vomiting—Apraclonidine—glaucoma	0.000315	0.000716	CcSEcCtD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.000314	0.00303	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—SLC6A1—glaucoma	0.000314	0.00303	CbGpPWpGaD
Amantadine—MAOB—Biological oxidations—CYP1B1—glaucoma	0.000314	0.00303	CbGpPWpGaD
Amantadine—Hypersensitivity—Brimonidine—glaucoma	0.000313	0.000713	CcSEcCtD
Amantadine—Dry mouth—Clonidine—glaucoma	0.000313	0.000711	CcSEcCtD
Amantadine—Dermatitis—Apraclonidine—glaucoma	0.000312	0.00071	CcSEcCtD
Amantadine—Headache—Apraclonidine—glaucoma	0.00031	0.000706	CcSEcCtD
Amantadine—Confusional state—Clonidine—glaucoma	0.000309	0.000703	CcSEcCtD
Amantadine—GRIN1—BDNF signaling pathway—BDNF—glaucoma	0.000309	0.00299	CbGpPWpGaD
Amantadine—Vision blurred—Betaxolol—glaucoma	0.000308	0.000701	CcSEcCtD
Amantadine—Oedema—Clonidine—glaucoma	0.000306	0.000697	CcSEcCtD
Amantadine—Tremor—Betaxolol—glaucoma	0.000306	0.000697	CcSEcCtD
Amantadine—GRIN2B—Neuronal System—SLC6A1—glaucoma	0.000306	0.00296	CbGpPWpGaD
Amantadine—Hallucination—Timolol—glaucoma	0.000305	0.000694	CcSEcCtD
Amantadine—Asthenia—Brimonidine—glaucoma	0.000305	0.000694	CcSEcCtD
Amantadine—Body temperature increased—Pilocarpine—glaucoma	0.000303	0.00069	CcSEcCtD
Amantadine—Diarrhoea—Acetazolamide—glaucoma	0.000303	0.000689	CcSEcCtD
Amantadine—Rash—Bimatoprost—glaucoma	0.000303	0.000689	CcSEcCtD
Amantadine—Dermatitis—Bimatoprost—glaucoma	0.000302	0.000688	CcSEcCtD
Amantadine—Oedema peripheral—Timolol—glaucoma	0.000302	0.000687	CcSEcCtD
Amantadine—GRIN2B—BDNF signaling pathway—BDNF—glaucoma	0.000301	0.00291	CbGpPWpGaD
Amantadine—Pruritus—Brimonidine—glaucoma	0.000301	0.000684	CcSEcCtD
Amantadine—Headache—Bimatoprost—glaucoma	0.000301	0.000684	CcSEcCtD
Amantadine—DDC—Circadian rythm related genes—NTRK1—glaucoma	0.000301	0.00291	CbGpPWpGaD
Amantadine—Nervous system disorder—Clonidine—glaucoma	0.000301	0.000683	CcSEcCtD
Amantadine—DDC—SIDS Susceptibility Pathways—NGF—glaucoma	0.000299	0.00289	CbGpPWpGaD
Amantadine—Hypersensitivity—Dorzolamide—glaucoma	0.000299	0.00068	CcSEcCtD
Amantadine—Tachycardia—Clonidine—glaucoma	0.000299	0.00068	CcSEcCtD
Amantadine—DDC—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000298	0.00288	CbGpPWpGaD
Amantadine—Hypersensitivity—Travoprost—glaucoma	0.000298	0.000678	CcSEcCtD
Amantadine—Skin disorder—Clonidine—glaucoma	0.000298	0.000677	CcSEcCtD
Amantadine—Hyperhidrosis—Clonidine—glaucoma	0.000296	0.000674	CcSEcCtD
Amantadine—Visual impairment—Timolol—glaucoma	0.000296	0.000672	CcSEcCtD
Amantadine—Nausea—Apraclonidine—glaucoma	0.000294	0.000669	CcSEcCtD
Amantadine—Hypersensitivity—Brinzolamide—glaucoma	0.000294	0.000669	CcSEcCtD
Amantadine—Dizziness—Acetazolamide—glaucoma	0.000293	0.000666	CcSEcCtD
Amantadine—Anorexia—Clonidine—glaucoma	0.000292	0.000664	CcSEcCtD
Amantadine—Asthenia—Dorzolamide—glaucoma	0.000291	0.000663	CcSEcCtD
Amantadine—SLC22A2—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000291	0.00281	CbGpPWpGaD
Amantadine—Asthenia—Travoprost—glaucoma	0.00029	0.00066	CcSEcCtD
Amantadine—GRIN1—SIDS Susceptibility Pathways—BDNF—glaucoma	0.00029	0.0028	CbGpPWpGaD
Amantadine—Palpitations—Betaxolol—glaucoma	0.000289	0.000657	CcSEcCtD
Amantadine—Pruritus—Dorzolamide—glaucoma	0.000287	0.000653	CcSEcCtD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000287	0.00277	CbGpPWpGaD
Amantadine—Eye disorder—Timolol—glaucoma	0.000287	0.000652	CcSEcCtD
Amantadine—Asthenia—Brinzolamide—glaucoma	0.000286	0.000651	CcSEcCtD
Amantadine—Hypotension—Clonidine—glaucoma	0.000286	0.000651	CcSEcCtD
Amantadine—Pruritus—Travoprost—glaucoma	0.000286	0.000651	CcSEcCtD
Amantadine—Nausea—Bimatoprost—glaucoma	0.000285	0.000649	CcSEcCtD
Amantadine—Cardiac disorder—Timolol—glaucoma	0.000285	0.000648	CcSEcCtD
Amantadine—Hypersensitivity—Pilocarpine—glaucoma	0.000283	0.000643	CcSEcCtD
Amantadine—Pruritus—Brinzolamide—glaucoma	0.000282	0.000642	CcSEcCtD
Amantadine—Vomiting—Acetazolamide—glaucoma	0.000282	0.000641	CcSEcCtD
Amantadine—Dizziness—Brimonidine—glaucoma	0.000281	0.00064	CcSEcCtD
Amantadine—Angiopathy—Timolol—glaucoma	0.000278	0.000633	CcSEcCtD
Amantadine—GRIN1—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000278	0.00269	CbGpPWpGaD
Amantadine—Diarrhoea—Dorzolamide—glaucoma	0.000278	0.000632	CcSEcCtD
Amantadine—Headache—Acetazolamide—glaucoma	0.000278	0.000631	CcSEcCtD
Amantadine—Anxiety—Betaxolol—glaucoma	0.000277	0.000631	CcSEcCtD
Amantadine—Insomnia—Clonidine—glaucoma	0.000277	0.00063	CcSEcCtD
Amantadine—Diarrhoea—Travoprost—glaucoma	0.000277	0.000629	CcSEcCtD
Amantadine—Mediastinal disorder—Timolol—glaucoma	0.000276	0.000629	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000276	0.000629	CcSEcCtD
Amantadine—MAOB—Metabolism—NARFL—glaucoma	0.000276	0.00267	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CA5A—glaucoma	0.000276	0.00267	CbGpPWpGaD
Amantadine—Asthenia—Pilocarpine—glaucoma	0.000275	0.000626	CcSEcCtD
Amantadine—Paraesthesia—Clonidine—glaucoma	0.000275	0.000626	CcSEcCtD
Amantadine—GRIN1—BDNF signaling pathway—NGF—glaucoma	0.000274	0.00265	CbGpPWpGaD
Amantadine—Arrhythmia—Timolol—glaucoma	0.000274	0.000623	CcSEcCtD
Amantadine—Dyspnoea—Clonidine—glaucoma	0.000273	0.000621	CcSEcCtD
Amantadine—Diarrhoea—Brinzolamide—glaucoma	0.000273	0.000621	CcSEcCtD
Amantadine—GRIN1—EPH-Ephrin signaling—MMP2—glaucoma	0.000273	0.00264	CbGpPWpGaD
Amantadine—GRIN2C—Alzheimers Disease—TNF—glaucoma	0.000273	0.00263	CbGpPWpGaD
Amantadine—Somnolence—Clonidine—glaucoma	0.000272	0.00062	CcSEcCtD
Amantadine—Dry mouth—Betaxolol—glaucoma	0.000272	0.000619	CcSEcCtD
Amantadine—Pruritus—Pilocarpine—glaucoma	0.000271	0.000617	CcSEcCtD
Amantadine—Alopecia—Timolol—glaucoma	0.000271	0.000617	CcSEcCtD
Amantadine—SLC22A1—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000271	0.00262	CbGpPWpGaD
Amantadine—Confusional state—Betaxolol—glaucoma	0.000269	0.000612	CcSEcCtD
Amantadine—Mental disorder—Timolol—glaucoma	0.000269	0.000611	CcSEcCtD
Amantadine—Dizziness—Dorzolamide—glaucoma	0.000269	0.000611	CcSEcCtD
Amantadine—Rash—Brimonidine—glaucoma	0.000268	0.00061	CcSEcCtD
Amantadine—Dermatitis—Brimonidine—glaucoma	0.000268	0.000609	CcSEcCtD
Amantadine—Dizziness—Travoprost—glaucoma	0.000267	0.000608	CcSEcCtD
Amantadine—GRIN2B—BDNF signaling pathway—NGF—glaucoma	0.000267	0.00258	CbGpPWpGaD
Amantadine—Malnutrition—Timolol—glaucoma	0.000267	0.000607	CcSEcCtD
Amantadine—Oedema—Betaxolol—glaucoma	0.000267	0.000607	CcSEcCtD
Amantadine—Headache—Brimonidine—glaucoma	0.000266	0.000606	CcSEcCtD
Amantadine—Decreased appetite—Clonidine—glaucoma	0.000266	0.000606	CcSEcCtD
Amantadine—GRIN2B—EPH-Ephrin signaling—MMP2—glaucoma	0.000266	0.00257	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000266	0.00257	CbGpPWpGaD
Amantadine—Gastrointestinal disorder—Clonidine—glaucoma	0.000265	0.000602	CcSEcCtD
Amantadine—Fatigue—Clonidine—glaucoma	0.000264	0.000601	CcSEcCtD
Amantadine—Dizziness—Brinzolamide—glaucoma	0.000264	0.0006	CcSEcCtD
Amantadine—Nausea—Acetazolamide—glaucoma	0.000263	0.000599	CcSEcCtD
Amantadine—Diarrhoea—Pilocarpine—glaucoma	0.000263	0.000597	CcSEcCtD
Amantadine—Tension—Timolol—glaucoma	0.000262	0.000596	CcSEcCtD
Amantadine—Constipation—Clonidine—glaucoma	0.000262	0.000596	CcSEcCtD
Amantadine—Nervous system disorder—Betaxolol—glaucoma	0.000262	0.000595	CcSEcCtD
Amantadine—Tachycardia—Betaxolol—glaucoma	0.00026	0.000592	CcSEcCtD
Amantadine—Nervousness—Timolol—glaucoma	0.000259	0.00059	CcSEcCtD
Amantadine—Skin disorder—Betaxolol—glaucoma	0.000259	0.000589	CcSEcCtD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000258	0.0025	CbGpPWpGaD
Amantadine—Vomiting—Dorzolamide—glaucoma	0.000258	0.000587	CcSEcCtD
Amantadine—Hyperhidrosis—Betaxolol—glaucoma	0.000258	0.000587	CcSEcCtD
Amantadine—GRIN1—SIDS Susceptibility Pathways—NGF—glaucoma	0.000257	0.00249	CbGpPWpGaD
Amantadine—Rash—Dorzolamide—glaucoma	0.000256	0.000582	CcSEcCtD
Amantadine—GRIN1—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000256	0.00247	CbGpPWpGaD
Amantadine—Dermatitis—Dorzolamide—glaucoma	0.000256	0.000582	CcSEcCtD
Amantadine—Rash—Travoprost—glaucoma	0.000255	0.00058	CcSEcCtD
Amantadine—Dermatitis—Travoprost—glaucoma	0.000255	0.000579	CcSEcCtD
Amantadine—Headache—Dorzolamide—glaucoma	0.000254	0.000579	CcSEcCtD
Amantadine—Anorexia—Betaxolol—glaucoma	0.000254	0.000578	CcSEcCtD
Amantadine—Vomiting—Brinzolamide—glaucoma	0.000254	0.000577	CcSEcCtD
Amantadine—Dizziness—Pilocarpine—glaucoma	0.000254	0.000577	CcSEcCtD
Amantadine—GRIN1—Developmental Biology—NCK2—glaucoma	0.000254	0.00245	CbGpPWpGaD
Amantadine—GRIN2D—Alzheimers Disease—TNF—glaucoma	0.000253	0.00245	CbGpPWpGaD
Amantadine—Headache—Travoprost—glaucoma	0.000253	0.000576	CcSEcCtD
Amantadine—Nausea—Brimonidine—glaucoma	0.000253	0.000574	CcSEcCtD
Amantadine—Feeling abnormal—Clonidine—glaucoma	0.000253	0.000574	CcSEcCtD
Amantadine—Rash—Brinzolamide—glaucoma	0.000252	0.000573	CcSEcCtD
Amantadine—Vision blurred—Timolol—glaucoma	0.000252	0.000572	CcSEcCtD
Amantadine—Dermatitis—Brinzolamide—glaucoma	0.000251	0.000572	CcSEcCtD
Amantadine—MAOB—Biological oxidations—GSTM1—glaucoma	0.000251	0.00242	CbGpPWpGaD
Amantadine—Headache—Brinzolamide—glaucoma	0.00025	0.000569	CcSEcCtD
Amantadine—Hypotension—Betaxolol—glaucoma	0.000249	0.000567	CcSEcCtD
Amantadine—SLC22A1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000248	0.00239	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—NCK2—glaucoma	0.000247	0.00239	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000246	0.00238	CbGpPWpGaD
Amantadine—Vomiting—Pilocarpine—glaucoma	0.000244	0.000555	CcSEcCtD
Amantadine—Body temperature increased—Clonidine—glaucoma	0.000242	0.000551	CcSEcCtD
Amantadine—Rash—Pilocarpine—glaucoma	0.000242	0.00055	CcSEcCtD
Amantadine—Dermatitis—Pilocarpine—glaucoma	0.000242	0.00055	CcSEcCtD
Amantadine—Insomnia—Betaxolol—glaucoma	0.000241	0.000549	CcSEcCtD
Amantadine—Nausea—Dorzolamide—glaucoma	0.000241	0.000549	CcSEcCtD
Amantadine—Headache—Pilocarpine—glaucoma	0.00024	0.000547	CcSEcCtD
Amantadine—GRIN2C—Alzheimers Disease—TP53—glaucoma	0.00024	0.00232	CbGpPWpGaD
Amantadine—Nausea—Travoprost—glaucoma	0.00024	0.000546	CcSEcCtD
Amantadine—Paraesthesia—Betaxolol—glaucoma	0.00024	0.000545	CcSEcCtD
Amantadine—Dyspnoea—Betaxolol—glaucoma	0.000238	0.000541	CcSEcCtD
Amantadine—Nausea—Brinzolamide—glaucoma	0.000237	0.000539	CcSEcCtD
Amantadine—Palpitations—Timolol—glaucoma	0.000236	0.000537	CcSEcCtD
Amantadine—DDC—Circadian rythm related genes—FAS—glaucoma	0.000236	0.00228	CbGpPWpGaD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000236	0.00228	CbGpPWpGaD
Amantadine—Dyspepsia—Betaxolol—glaucoma	0.000235	0.000534	CcSEcCtD
Amantadine—Decreased appetite—Betaxolol—glaucoma	0.000232	0.000527	CcSEcCtD
Amantadine—Hypertension—Timolol—glaucoma	0.000231	0.000524	CcSEcCtD
Amantadine—Gastrointestinal disorder—Betaxolol—glaucoma	0.00023	0.000524	CcSEcCtD
Amantadine—Fatigue—Betaxolol—glaucoma	0.00023	0.000523	CcSEcCtD
Amantadine—Constipation—Betaxolol—glaucoma	0.000228	0.000519	CcSEcCtD
Amantadine—Nausea—Pilocarpine—glaucoma	0.000228	0.000518	CcSEcCtD
Amantadine—Anxiety—Timolol—glaucoma	0.000227	0.000515	CcSEcCtD
Amantadine—GRIN1—BDNF signaling pathway—BAD—glaucoma	0.000226	0.00219	CbGpPWpGaD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000226	0.000514	CcSEcCtD
Amantadine—Hypersensitivity—Clonidine—glaucoma	0.000226	0.000513	CcSEcCtD
Amantadine—GRIN2D—Alzheimers Disease—TP53—glaucoma	0.000223	0.00216	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—SLC6A13—glaucoma	0.000223	0.00215	CbGpPWpGaD
Amantadine—Dry mouth—Timolol—glaucoma	0.000222	0.000506	CcSEcCtD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000221	0.00214	CbGpPWpGaD
Amantadine—GRIN2B—BDNF signaling pathway—BAD—glaucoma	0.00022	0.00213	CbGpPWpGaD
Amantadine—Asthenia—Clonidine—glaucoma	0.00022	0.0005	CcSEcCtD
Amantadine—Feeling abnormal—Betaxolol—glaucoma	0.00022	0.0005	CcSEcCtD
Amantadine—Confusional state—Timolol—glaucoma	0.00022	0.0005	CcSEcCtD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.00022	0.00212	CbGpPWpGaD
Amantadine—Anaphylactic shock—Timolol—glaucoma	0.000218	0.000496	CcSEcCtD
Amantadine—Oedema—Timolol—glaucoma	0.000218	0.000496	CcSEcCtD
Amantadine—Pruritus—Clonidine—glaucoma	0.000217	0.000493	CcSEcCtD
Amantadine—Nervous system disorder—Timolol—glaucoma	0.000214	0.000486	CcSEcCtD
Amantadine—SLC22A2—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000213	0.00206	CbGpPWpGaD
Amantadine—Skin disorder—Timolol—glaucoma	0.000212	0.000481	CcSEcCtD
Amantadine—Body temperature increased—Betaxolol—glaucoma	0.000211	0.00048	CcSEcCtD
Amantadine—Hyperhidrosis—Timolol—glaucoma	0.000211	0.000479	CcSEcCtD
Amantadine—Diarrhoea—Clonidine—glaucoma	0.00021	0.000477	CcSEcCtD
Amantadine—GRIN2A—Alzheimers Disease—TNF—glaucoma	0.000208	0.00201	CbGpPWpGaD
Amantadine—Anorexia—Timolol—glaucoma	0.000208	0.000472	CcSEcCtD
Amantadine—SLC22A1—Neuronal System—SLC6A13—glaucoma	0.000208	0.00201	CbGpPWpGaD
Amantadine—GRIN1—EPH-Ephrin signaling—MMP9—glaucoma	0.000205	0.00198	CbGpPWpGaD
Amantadine—Hypotension—Timolol—glaucoma	0.000204	0.000463	CcSEcCtD
Amantadine—Dizziness—Clonidine—glaucoma	0.000203	0.000461	CcSEcCtD
Amantadine—GRIN2B—EPH-Ephrin signaling—MMP9—glaucoma	0.0002	0.00193	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000198	0.00192	CbGpPWpGaD
Amantadine—Insomnia—Timolol—glaucoma	0.000197	0.000448	CcSEcCtD
Amantadine—Hypersensitivity—Betaxolol—glaucoma	0.000197	0.000447	CcSEcCtD
Amantadine—Paraesthesia—Timolol—glaucoma	0.000196	0.000445	CcSEcCtD
Amantadine—GRIN1—Spinal Cord Injury—PTGS2—glaucoma	0.000195	0.00189	CbGpPWpGaD
Amantadine—Vomiting—Clonidine—glaucoma	0.000195	0.000443	CcSEcCtD
Amantadine—Dyspnoea—Timolol—glaucoma	0.000194	0.000442	CcSEcCtD
Amantadine—Somnolence—Timolol—glaucoma	0.000194	0.000441	CcSEcCtD
Amantadine—Rash—Clonidine—glaucoma	0.000193	0.000439	CcSEcCtD
Amantadine—Dermatitis—Clonidine—glaucoma	0.000193	0.000439	CcSEcCtD
Amantadine—Headache—Clonidine—glaucoma	0.000192	0.000437	CcSEcCtD
Amantadine—Dyspepsia—Timolol—glaucoma	0.000192	0.000436	CcSEcCtD
Amantadine—Asthenia—Betaxolol—glaucoma	0.000191	0.000435	CcSEcCtD
Amantadine—Decreased appetite—Timolol—glaucoma	0.000189	0.000431	CcSEcCtD
Amantadine—Pruritus—Betaxolol—glaucoma	0.000189	0.000429	CcSEcCtD
Amantadine—Gastrointestinal disorder—Timolol—glaucoma	0.000188	0.000428	CcSEcCtD
Amantadine—Fatigue—Timolol—glaucoma	0.000188	0.000427	CcSEcCtD
Amantadine—DRD2—GPCR ligand binding—OPN4—glaucoma	0.000187	0.00181	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—CDKN1B—glaucoma	0.000185	0.00179	CbGpPWpGaD
Amantadine—GRIN1—EPH-Ephrin signaling—VEGFA—glaucoma	0.000184	0.00178	CbGpPWpGaD
Amantadine—GRIN2A—Alzheimers Disease—TP53—glaucoma	0.000183	0.00177	CbGpPWpGaD
Amantadine—Diarrhoea—Betaxolol—glaucoma	0.000183	0.000415	CcSEcCtD
Amantadine—Nausea—Clonidine—glaucoma	0.000182	0.000414	CcSEcCtD
Amantadine—GRIN1—Alzheimers Disease—TNF—glaucoma	0.000181	0.00175	CbGpPWpGaD
Amantadine—GRIN2B—EPH-Ephrin signaling—VEGFA—glaucoma	0.00018	0.00174	CbGpPWpGaD
Amantadine—Feeling abnormal—Timolol—glaucoma	0.00018	0.000408	CcSEcCtD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000179	0.00174	CbGpPWpGaD
Amantadine—GRIN2B—Alzheimers Disease—TNF—glaucoma	0.000177	0.00171	CbGpPWpGaD
Amantadine—Dizziness—Betaxolol—glaucoma	0.000176	0.000401	CcSEcCtD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000172	0.00167	CbGpPWpGaD
Amantadine—Body temperature increased—Timolol—glaucoma	0.000172	0.000392	CcSEcCtD
Amantadine—GRIN1—Spinal Cord Injury—MMP9—glaucoma	0.000171	0.00165	CbGpPWpGaD
Amantadine—Vomiting—Betaxolol—glaucoma	0.00017	0.000386	CcSEcCtD
Amantadine—DRD2—GPCR ligand binding—PTGFR—glaucoma	0.000169	0.00163	CbGpPWpGaD
Amantadine—Rash—Betaxolol—glaucoma	0.000168	0.000383	CcSEcCtD
Amantadine—Dermatitis—Betaxolol—glaucoma	0.000168	0.000382	CcSEcCtD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000167	0.00162	CbGpPWpGaD
Amantadine—Headache—Betaxolol—glaucoma	0.000167	0.00038	CcSEcCtD
Amantadine—GRIN1—Developmental Biology—PAX6—glaucoma	0.000164	0.00159	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—SLC6A1—glaucoma	0.000163	0.00158	CbGpPWpGaD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000161	0.00155	CbGpPWpGaD
Amantadine—Hypersensitivity—Timolol—glaucoma	0.000161	0.000365	CcSEcCtD
Amantadine—GRIN2B—Developmental Biology—PAX6—glaucoma	0.00016	0.00155	CbGpPWpGaD
Amantadine—DDC—Metabolism—CA1—glaucoma	0.00016	0.00155	CbGpPWpGaD
Amantadine—GRIN1—Alzheimers Disease—TP53—glaucoma	0.00016	0.00155	CbGpPWpGaD
Amantadine—Nausea—Betaxolol—glaucoma	0.000158	0.00036	CcSEcCtD
Amantadine—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.000158	0.00153	CbGpPWpGaD
Amantadine—Asthenia—Timolol—glaucoma	0.000156	0.000356	CcSEcCtD
Amantadine—GRIN2B—Alzheimers Disease—TP53—glaucoma	0.000156	0.00151	CbGpPWpGaD
Amantadine—DDC—Metabolism—CTSA—glaucoma	0.000155	0.0015	CbGpPWpGaD
Amantadine—Pruritus—Timolol—glaucoma	0.000154	0.000351	CcSEcCtD
Amantadine—SLC22A1—Neuronal System—SLC6A1—glaucoma	0.000152	0.00147	CbGpPWpGaD
Amantadine—Diarrhoea—Timolol—glaucoma	0.000149	0.000339	CcSEcCtD
Amantadine—SLC22A2—Metabolism—CA5A—glaucoma	0.000146	0.00141	CbGpPWpGaD
Amantadine—DDC—Metabolism—CA2—glaucoma	0.000146	0.00141	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—NARFL—glaucoma	0.000146	0.00141	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000145	0.0014	CbGpPWpGaD
Amantadine—Dizziness—Timolol—glaucoma	0.000144	0.000328	CcSEcCtD
Amantadine—DDC—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000143	0.00138	CbGpPWpGaD
Amantadine—Vomiting—Timolol—glaucoma	0.000139	0.000315	CcSEcCtD
Amantadine—Rash—Timolol—glaucoma	0.000137	0.000313	CcSEcCtD
Amantadine—Dermatitis—Timolol—glaucoma	0.000137	0.000312	CcSEcCtD
Amantadine—Headache—Timolol—glaucoma	0.000137	0.000311	CcSEcCtD
Amantadine—SLC22A1—Metabolism—CA5A—glaucoma	0.000136	0.00132	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—NARFL—glaucoma	0.000136	0.00132	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—IL1A—glaucoma	0.000136	0.00132	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CA1—glaucoma	0.000135	0.0013	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—TNF—glaucoma	0.000132	0.00127	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CTSA—glaucoma	0.00013	0.00126	CbGpPWpGaD
Amantadine—Nausea—Timolol—glaucoma	0.000129	0.000294	CcSEcCtD
Amantadine—DRD2—Circadian rythm related genes—NGFR—glaucoma	0.000125	0.00121	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CA2—glaucoma	0.000123	0.00119	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000123	0.00119	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—TNF—glaucoma	0.000123	0.00118	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—FAS—glaucoma	0.000121	0.00117	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00012	0.00116	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—C3—glaucoma	0.00012	0.00116	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—NTRK1—glaucoma	0.000119	0.00115	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—TP53—glaucoma	0.000116	0.00112	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000112	0.00108	CbGpPWpGaD
Amantadine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	0.000106	0.00102	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—OPN4—glaucoma	0.000106	0.00102	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—TNF—glaucoma	0.000105	0.00102	CbGpPWpGaD
Amantadine—DDC—Metabolism—TXN—glaucoma	0.000103	0.000997	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000103	0.000991	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—MMP2—glaucoma	0.000101	0.000981	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—MMP2—glaucoma	9.89e-05	0.000956	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	9.8e-05	0.000948	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—OPN4—glaucoma	9.6e-05	0.000929	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PTGFR—glaucoma	9.52e-05	0.000921	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—FAS—glaucoma	9.29e-05	0.000898	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—TP53—glaucoma	8.82e-05	0.000853	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	8.76e-05	0.000847	CbGpPWpGaD
Amantadine—MAOB—Metabolism—TXN—glaucoma	8.68e-05	0.000839	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PTGFR—glaucoma	8.65e-05	0.000836	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—SMO—glaucoma	8.5e-05	0.000821	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—LRP12—glaucoma	8.19e-05	0.000791	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC6A1—glaucoma	8.17e-05	0.00079	CbGpPWpGaD
Amantadine—DRD2—G alpha (i) signalling events—C3—glaucoma	8.08e-05	0.000781	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—NARFL—glaucoma	8e-05	0.000773	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CA5A—glaucoma	8e-05	0.000773	CbGpPWpGaD
Amantadine—DDC—Metabolism—GSTT1—glaucoma	8e-05	0.000773	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	7.65e-05	0.000739	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—MMP9—glaucoma	7.62e-05	0.000737	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—MMP9—glaucoma	7.43e-05	0.000719	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	7.36e-05	0.000711	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—MMP2—glaucoma	7.24e-05	0.0007	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CA1—glaucoma	7.15e-05	0.000691	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—MMP2—glaucoma	7.06e-05	0.000682	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	7.05e-05	0.000681	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	7e-05	0.000677	CbGpPWpGaD
Amantadine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	6.94e-05	0.000671	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CTSA—glaucoma	6.92e-05	0.000669	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—VEGFA—glaucoma	6.85e-05	0.000662	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GSTT1—glaucoma	6.73e-05	0.000651	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—VEGFA—glaucoma	6.67e-05	0.000645	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CA1—glaucoma	6.66e-05	0.000644	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	6.54e-05	0.000632	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CA2—glaucoma	6.54e-05	0.000632	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CTSA—glaucoma	6.45e-05	0.000624	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	6.43e-05	0.000621	CbGpPWpGaD
Amantadine—DDC—Metabolism—ABCA1—glaucoma	6.37e-05	0.000616	CbGpPWpGaD
Amantadine—DDC—Metabolism—CYP1B1—glaucoma	6.37e-05	0.000616	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CA2—glaucoma	6.09e-05	0.000589	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—VEGFA—glaucoma	6.01e-05	0.000581	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	5.99e-05	0.000579	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—OPN4—glaucoma	5.67e-05	0.000549	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—EDN1—glaucoma	5.6e-05	0.000542	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—MMP9—glaucoma	5.44e-05	0.000526	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CYP1B1—glaucoma	5.36e-05	0.000518	CbGpPWpGaD
Amantadine—MAOB—Metabolism—ABCA1—glaucoma	5.36e-05	0.000518	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—MMP9—glaucoma	5.3e-05	0.000513	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HEYL—glaucoma	5.27e-05	0.00051	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—TNF—glaucoma	5.15e-05	0.000498	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	5.12e-05	0.000495	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PTGFR—glaucoma	5.11e-05	0.000494	CbGpPWpGaD
Amantadine—DDC—Metabolism—GSTM1—glaucoma	5.09e-05	0.000492	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—C3—glaucoma	4.89e-05	0.000473	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—VEGFA—glaucoma	4.89e-05	0.000472	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.79e-05	0.000463	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—VEGFA—glaucoma	4.76e-05	0.00046	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—TXN—glaucoma	4.61e-05	0.000445	CbGpPWpGaD
Amantadine—DDC—Metabolism—MTHFR—glaucoma	4.5e-05	0.000435	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—SMO—glaucoma	4.36e-05	0.000422	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—TXN—glaucoma	4.29e-05	0.000415	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GSTM1—glaucoma	4.29e-05	0.000414	CbGpPWpGaD
Amantadine—DDC—Metabolism—APOE—glaucoma	4.19e-05	0.000405	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—TNF—glaucoma	4.19e-05	0.000405	CbGpPWpGaD
Amantadine—DDC—Metabolism—CAV1—glaucoma	4.15e-05	0.000401	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—TNF—glaucoma	4.08e-05	0.000395	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RPTOR—glaucoma	4e-05	0.000386	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CA1—glaucoma	3.9e-05	0.000377	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NCK2—glaucoma	3.87e-05	0.000374	CbGpPWpGaD
Amantadine—MAOB—Metabolism—MTHFR—glaucoma	3.79e-05	0.000366	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CTSA—glaucoma	3.78e-05	0.000366	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	3.77e-05	0.000364	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CA2—glaucoma	3.57e-05	0.000345	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GSTT1—glaucoma	3.57e-05	0.000345	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	3.57e-05	0.000345	CbGpPWpGaD
Amantadine—MAOB—Metabolism—APOE—glaucoma	3.53e-05	0.000341	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CAV1—glaucoma	3.49e-05	0.000338	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—TP53—glaucoma	3.48e-05	0.000336	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GSTT1—glaucoma	3.33e-05	0.000322	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HDAC9—glaucoma	3.29e-05	0.000318	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—EDN1—glaucoma	3.17e-05	0.000306	CbGpPWpGaD
Amantadine—DDC—Metabolism—NOS3—glaucoma	3.14e-05	0.000303	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	2.97e-05	0.000287	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—EDN1—glaucoma	2.87e-05	0.000278	CbGpPWpGaD
Amantadine—DDC—Metabolism—PTGS2—glaucoma	2.87e-05	0.000278	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CYP1B1—glaucoma	2.85e-05	0.000275	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ABCA1—glaucoma	2.85e-05	0.000275	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—C3—glaucoma	2.77e-05	0.000267	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CYP1B1—glaucoma	2.65e-05	0.000256	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ABCA1—glaucoma	2.65e-05	0.000256	CbGpPWpGaD
Amantadine—MAOB—Metabolism—NOS3—glaucoma	2.64e-05	0.000255	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SMO—glaucoma	2.58e-05	0.000249	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.54e-05	0.000246	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—TXN—glaucoma	2.52e-05	0.000243	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—C3—glaucoma	2.51e-05	0.000243	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PTGS2—glaucoma	2.42e-05	0.000234	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NTRK2—glaucoma	2.36e-05	0.000228	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GSTM1—glaucoma	2.27e-05	0.00022	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.24e-05	0.000217	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GSTM1—glaucoma	2.12e-05	0.000205	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NGFR—glaucoma	2.02e-05	0.000195	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—MTHFR—glaucoma	2.01e-05	0.000194	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTT1—glaucoma	1.95e-05	0.000189	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NTRK1—glaucoma	1.92e-05	0.000186	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—MTHFR—glaucoma	1.87e-05	0.000181	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—APOE—glaucoma	1.87e-05	0.000181	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CAV1—glaucoma	1.85e-05	0.000179	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CDKN2B—glaucoma	1.77e-05	0.000171	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—APOE—glaucoma	1.74e-05	0.000169	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CAV1—glaucoma	1.73e-05	0.000167	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—EDN1—glaucoma	1.7e-05	0.000164	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NGF—glaucoma	1.56e-05	0.000151	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP1B1—glaucoma	1.55e-05	0.00015	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ABCA1—glaucoma	1.55e-05	0.00015	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—C3—glaucoma	1.48e-05	0.000143	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—NOS3—glaucoma	1.4e-05	0.000136	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—APOE—glaucoma	1.38e-05	0.000134	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CAV1—glaucoma	1.37e-05	0.000132	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—NOS3—glaucoma	1.31e-05	0.000126	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FN1—glaucoma	1.3e-05	0.000126	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—BAD—glaucoma	1.29e-05	0.000124	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PTGS2—glaucoma	1.28e-05	0.000124	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTM1—glaucoma	1.24e-05	0.00012	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PTGS2—glaucoma	1.2e-05	0.000116	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—MTHFR—glaucoma	1.1e-05	0.000106	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NOS3—glaucoma	1.03e-05	0.0001	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—APOE—glaucoma	1.02e-05	9.89e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CAV1—glaucoma	1.01e-05	9.79e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CDKN1B—glaucoma	8.96e-06	8.67e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MMP9—glaucoma	8.3e-06	8.03e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—NOS3—glaucoma	7.66e-06	7.41e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—VEGFA—glaucoma	7.45e-06	7.21e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PTGS2—glaucoma	7.01e-06	6.77e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TP53—glaucoma	5.63e-06	5.45e-05	CbGpPWpGaD
